Protocol-based Fluid Management for Critical Illness
(Probe-Fluid Trial)
Trial Summary
What is the purpose of this trial?
This trial tests a method to manage fluid levels in critically ill patients with severe kidney issues. The goal is to prevent and treat fluid buildup by removing excess fluid, potentially improving patient outcomes.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Protocol-based Fluid Management for Critical Illness?
Is protocol-based fluid management generally safe for humans?
Protocol-based fluid management in critically ill patients was associated with improved survival in the ICU, suggesting it is generally safe when used correctly. However, adverse events related to fluid management can occur, especially during transitions from the ICU, indicating the need for careful monitoring.26789
How does protocol-based fluid management differ from other treatments for critical illness?
Protocol-based fluid management is unique because it involves a structured approach where healthcare providers follow specific guidelines to administer fluids, ensuring precise and timely care. This method requires close cooperation between doctors and nurses and uses computerized documentation to monitor patient responses, which can lead to improved survival rates in the ICU compared to more traditional, less structured fluid management strategies.2351011
Research Team
William Beaubien-Souligny, MD PhD
Principal Investigator
CHUM
Ron Wald, MDCM MPH
Principal Investigator
Unity Health Toronto
Sean Bagshaw, MD MSc
Principal Investigator
University of Alberta
Eligibility Criteria
This trial is for adults over 18 in the ICU with acute kidney injury (AKI) who meet specific criteria related to changes in serum creatinine or urine output. They must be starting kidney replacement therapy soon or have started it within the last 48 hours. People can't join if they're not expected to receive full support, might leave ICU soon, have severe burns, extreme sodium levels, ongoing fluid loss, or if their care team thinks the trial isn't right for them.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a protocol-based fluid management strategy or usual care for fluid balance management
Follow-up
Participants are monitored for safety and effectiveness after treatment
Extension
Participants may continue to be monitored for long-term outcomes and resource utilization
Treatment Details
Interventions
- Protocol-based fluid management (Fluid Management)
- Usual care (Other)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Centre hospitalier de l'Université de Montréal (CHUM)
Lead Sponsor